Table. Patient Characteristics.
Characteristic | No. (%) |
---|---|
Age at diagnosis in years, median (IQR), y | 61.5 (55.3-67.0) |
Grade group at diagnosis | |
I | 10 (11.1) |
II | 13 (14.4) |
III | 10 (11.1) |
IV | 17 (18.9) |
V | 27 (30.1) |
Unknown | 13 (14.4) |
PSA at diagnosis, median (IQR) | 15.2 (7.0-84.1) |
Primary local therapy | |
Radical prostatectomy | 24 (26.7) |
External beam radiation therapy | 24 (26.7) |
Brachytherapy | 10 (11.1) |
None | 32 (35.5) |
Ketoconazole dose | |
400 mg every 8 h | 75 (83.3) |
200 mg every 8 h | 8 (8.9) |
Unknown | 7 (7.8) |
HSD3B1 Genotype | |
Homozygous wild type | 44 (49.0) |
Heterozygous | 34 (38.0) |
Homozygous variant | 12 (13.0) |
Abbreviations: IQR, interquartile range; PSA, prostate-specific antigen.